Journal of Bone and Joint Surgery - British Volume · 2002 · 60 citations · 18 references
MedicineOncologySurgeryOrthopaedic OncologyOrthopedic OncologySurgical OncologyBone PathologyBone TumorsChemotherapy For Bone SarcomaMalignant NeoplasmsSarcoma SurgeryTumor MarkersBone Tumor PrognosisCox RegressionDisease-free Survival AnalysisDisease-free Survival AssessmentImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical Staining
We studied 55 patients with stage-IIB osteosarcoma around the knee with respect to the expression of matrix metalloproteinase (MMP)-9 in the surviving tumour cells in surgical resection specimens. They were followed up for a minimum of 2.5 years. Factors significantly associated with poor overall survival were a high serum level of alkaline phosphatase at diagnosis and tumour cells expressing MMP-9 in the resection specimens. The only factor strongly associated with disease-free survival was the immunohistochemical status of tumour cells for MMP-9 in the resection specimens. The percentage of necrosis after chemotherapy failed marginally to reach statistical significance. On Cox regression analysis only MMP-9 remained significant for overall and disease-free survival.
18
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Gabriele Bergers, Rolf A. Brekken, Gerald McMahon et al. · Nature Cell Biology · 2000 · 2.8K citations · Full text
Medicine, Cancer Biology, Oncology +14
Osteogenic sarcoma. A study of six hundred cases.
David C. Dahlin, Mark B. Coventry · PubMed · 1967 · 476 citations
Judah Folkman · Scientific American · 1976 · 323 citations
Medicine, Cancer Biology, Oncology +10